Black Rock Inc. Fortress Biotech, Inc. Transaction History

Black Rock Inc.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$0.28 - $0.65 $28,651 - $66,513	-102,328 Reduced 8.34%	1,124,112 $325,000
Q2 2023 Aug 11, 2023	SELL	$0.49 - $0.82 $87,298 - $146,091	-178,160 Reduced 12.68%	1,226,440 $674,000
Q1 2023 May 12, 2023	SELL	$0.65 - $1.1 $2,499 - $4,229	-3,845 Reduced 0.27%	1,404,600 $1.15 Million
Q4 2022 Feb 13, 2023	BUY	$0.48 - $13.5 $411 - $11,569	857 Added 0.06%	1,408,445 $929,000
Q3 2022 Nov 14, 2022	SELL	$0.79 - $22.0 $6,511 - $181,324	-8,242 Reduced 0.58%	1,407,588 $1.21 Million
Q2 2022 Aug 12, 2022	SELL	$0.8 - $1.5 $2.64 Million - $4.95 Million	-3,301,547 Reduced 69.99%	1,415,830 $1.19 Million
Q1 2022 May 12, 2022	SELL	$1.24 - $2.75 $70,534 - $156,428	-56,883 Reduced 1.19%	4,717,377 $6.42 Million
Q4 2021 Feb 10, 2022	BUY	$2.42 - $3.65 $280,473 - $423,027	115,898 Added 2.49%	4,774,260 $11.9 Million
Q3 2021 Nov 09, 2021	SELL	$2.82 - $3.7 $24,911 - $32,685	-8,834 Reduced 0.19%	4,658,362 $15 Million
Q2 2021 Aug 11, 2021	BUY	$3.5 - $5.48 $16.3 Million - $25.6 Million	4,667,196 New	4,667,196 $16.7 Million

862K

Ticker FBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,735,000
Market Cap $185M
Description
Fortress Biotech, Inc., a biopharmaceutical company, develops and commercializes pharmaceutical and biotechnology products. The company markets dermatology products, such as Ximino capsules to treat only inflammatory lesions of non-nodular moderate to severe acne vulgaris; Targadox for severe acne; Exelderm cream for ringworm and jock itch sympt...

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

Stay updated on Black Rock Inc. with notifications on news.